[HTML][HTML] Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study

M Sommer, LK Nielsen, LB Nielsen… - Health and Quality of …, 2021 - Springer
Background Patients with hematological cancer who experience relapse or progressive
disease often face yet another line of treatment and continued mortality risk that could increase …

Implementing a data infrastructure for precision oncology projects leveraging REDCap

…, IS Pedersen, M Sommer, AS Rytter, MM Nielsen… - medRxiv, 2022 - medrxiv.org
Objectives To facilitate clinical implementation and research in precision oncology, notably
the pairing of patients, variants and treatments to identify candidates for clinical trials, we …

Haematological cancer patients are positive towards gene testing

M Sommer, MM Nielsen, C Vesteghem, M Bøgsted… - 2018 - vbn.aau.dk
Aalborg Universitet Haematological cancer patients are positive towards gene testing
Sommer, Mia; Nielsen, Marlene Maria; Vesteg … Sommer, M., Nielsen, MM, Vesteghem, C …

Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients

…, C Vesteghem, M Sommer, MM Nielsen… - Basic & Clinical …, 2018 - vbn.aau.dk
… Laursen, Henrik Vitus Bering; Vesteghem, Charles; Sommer, Mia; Nielsen, Marlene Maria;
Dybkær, Karen; El-Galaly, Tarec; Johnsen, Hans Erik; Ehlers, Lars Holger; Bøgsted, Martin …

[CITATION][C] Hematological cancer patients' position on precision medicine: A questionnaire survey

M Sommer, MM Nielsen, C Vesteghem… - Basic & Clinical …, 2018 - ucviden.dk
… Mia Sommer, Marlene Maria Nielsen, Charles Vesteghem, Martin Bøgsted, Karen
Dybkaer, Hans Erik Johnsen, Tarec Christoffer El-Galaly, Rasmus Froberg Brøndum …

Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study

…, N Borty, B Froberg, N Maria… - Health and Quality of …, 2021 - jglobal.jst.go.jp
JAMA Oncol; Global, regional, and national cancer incidence, mortality, years of life lost, years
lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: …

Functional megalin is expressed in renal cysts in a mouse model of adult polycystic kidney disease

ML Nielsen, MC Mundt, DL Lildballe… - Clinical Kidney …, 2021 - academic.oup.com
Background Autosomal dominant polycystic kidney disease (ADPKD) is characterized by
the progressive growth of cysts and a decline of renal function. The clinical feasibility of the …

[HTML][HTML] Clinical genetic diagnostics in Danish autosomal dominant polycystic kidney disease patients reveal possible founder variants

ML Nielsen, DL Lildballe, M Rasmussen… - European Journal of …, 2021 - Elsevier
Background Autosomal dominant polycystic kidney disease (ADPKD) is the most common
heritable kidney disease. ADPKD leads to cysts, kidney enlargement and end-stage renal …

[BOOK][B] Marlene: Marlene Dietrich, a Personal Biography

C Chandler - 2011 - books.google.com
In Marlene, the legendary Hollywood icon is vividly brought to life, based on a series of
conversations with the star herself and with others who knew her well. In the mid-1970s Charlotte …

P0036 THE EFFECT OF CKD ASSOCIATED SNPS ON THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

ML Nielsen, DL Lildballe, M Jørgensen… - Nephrology Dialysis …, 2020 - academic.oup.com
Background and Aims Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most
frequent, inherited, cystic kidney disease. It is characterized by formation and growth of …